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Abstract
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a structurally endogenous peptide with many biological roles.
Maxadilan, a 61-amino acid vasodilatory peptide, specifically activates the PACAP type I receptor (PAC1). Although PAC1 has
been identified in embryonic stem cells, little is known about its presence or effects in human induced pluripotent stem
(iPS) cells. In the present study, we investigated the expression of PAC1 in human iPS cells by reverse transcriptase
polymerase chain reaction (RT-PCR) and western blot analysis. To study the physiological effects mediated by PAC1, we
evaluated the role of maxadilan in preventing apoptotic cell death induced by ultraviolet C (UVC). After exposure to UVC,
the iPS cells showed a marked reduction in cell viability and a parallel increase of apoptotic cells, as demonstrated by WST-8
analysis, annexin V/propidium iodide (PI) analysis and the terminal transferase dUTP nick end labeling (TUNEL) assay. The
addition of 30 nM of maxadilan dramatically increased iPS cell viability and reduced the percentage of apoptotic cells. The
anti-apoptotic effects of maxadilan were correlated to the downregulation of caspase-3 and caspase-9. Concomitantly,
immunofluorescence, western blot analysis, real-time quantitative polymerase chain reaction (RT-qPCR) analysis and in vitro
differentiation results showed that maxadilan did not affect the pluripotent state of iPS cells. Moreover, karyotype analysis
showed that maxadilan did not affect the karyotype of iPS cells. In summary, these results demonstrate that PAC1 is present
in iPS cells and that maxadilan effectively protects iPS cells against UVC-induced apoptotic cell death while not affecting the
pluripotent state or karyotype.
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Introduction
Traditional stem cell therapies face various impediments,
including the ethical and immunological challenges to clinical
application. In 2006, Takahashi and Yamanaka published an
article in Cell that ushered in a new era of stem cell research.
Through the retrovirus-mediated transfection of four transcription
factors (Oct4, SOX2, c-Myc, and Klf-4), they successfully
reprogrammed murine fibroblasts into a state that was similar to
an embryonic stem cell [1], a type of reprogrammed cell termed
an induced pluripotent stem (iPS) cell. These iPS cells were
difficult to distinguish from embryonic stem (ES) cells in
morphology, proliferative abilities, surface antigens, gene expres-
sion, epigenetic status of pluripotent cell-specific genes and
telomerase activity [2]. The generation of iPS cells has provided
great promise for studying human diseases without provoking
ethical and immunological problems. In addition to in vitro disease
modeling, these cells could be utilized for many toxicological and
pharmaceutical applications. The potential use of iPS cells, which
can be generated from any patient to produce genetically identical
pluripotent cells or patient-specific cells for therapy, has provoked
enormous investigative interest within the scientific community.
Although substantial progress has been made over the past few
years to characterize iPS cells and the techniques used to culture
iPS cells have greatly improved, iPS cells remain vulnerable to
undergoing apoptosis [3]. The identification of an anti-apoptotic
drug that can effectively prevent apoptosis in the iPS cell culture
medium will be important for generating iPS cells at a scale that
can accommodate future clinical applications.
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a
bioactive peptide isolated from ovine hypothalamic tissues with
two bioactive forms, consisting of either 38 (PACAP-38) or 27
(PACAP-27) amino acid residues. PACAP exerts its actions
through at least three distinct receptors: PACAP receptor 1
(PAC1), VIP receptor 1 and VIP receptor 2 [4]. Maxadilan, a 61-
amino acid vasodilatory peptide, was initially isolated from the
salivary glands of the sand fly Lutzomyia longipalpis. Although it
shares no significant sequence homology with PACAP, maxadilan
has been shown to be a PAC1-specific agonist, thereby serving as a
useful tool to investigate the functions of PACAP mediated
through PAC1 in diverse physiological settings [5]. PACAP and its
receptor PAC1 can protect cells from apoptosis. Kanekar S et al.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33953[6] reported that both PACAP and maxadilan could prevent
TNFa-mediated cell death in olfactory placodal cells and that
PACAP protects the mouse olfactory epithelium cells against
axotomy-induced apoptosis. Racz B et al. [7] reported that
PACAP effectively protects cochlear cells against oxidative stress-
induced apoptotic cell death. Gasz B et al. [8] showed that PACAP
was able to attenuate oxidative stress-induced cardiomyocyte
apoptosis. In 2004,Cazillis M et al. [9] demonstrated that PAC1 is
expressed and functional in mouse embryonic stem (ES) cells.
Soon after, Hirose M et al. [10] also identified that PAC1 is
present in ES cells. However, little is known about the presence
and effects of PAC1 in iPS cells. In this study, the expression or
absence of PAC1 in iPS cells was investigated, and maxadilan was
subsequently used to probe the anti-apoptotic effects mediated by
PAC1 in iPS cells. This research attempted to understand if
maxadilan could be an additive to facilitate large-scale culturing of
iPS cells.
Materials and Methods
Cell culture conditions and drug treatments
The UMC human iPS cell line was used in all experiments. This
iPS cell line was established from the umbilical cord matrix and
amniotic membrane mesenchymal cells by transduction of
retroviral factors, including Oct4, SOX2, c-Myc, and Klf4 [11].
The cells were cultured under feeder-free culture conditions.
Briefly, iPS cells were cultured in mTeSR1 medium (STEM
CELL) on dishes coated with Matrigel (Sigma-Aldrich). The cells
were grown in 5% CO2 with 95% humidity. The cell medium was
changed daily, and spontaneously differentiated colonies were
removed when appropriate. iPS cells were passaged every six days
with 0.05% trypsin-EDTA (STEM CELL) at 37uC for 3–5 min.
When colonies near the edge of the plate began to dissociate from
the bottom, the enzyme was removed, and colonies were washed
with mTeSR1 medium. Cells were collected by gently pipetting
and replated onto fresh Matrigel-coated dishes. The ROCK
inhibitor Y-27632 (10 mM) was added to each well for the first day
after each passage.
Western blot analysis
PAC1 was detected by western blot analysis in iPS cells. iPS cells
were pretreated with 100 nM of maxadilan for 24 h and passaged
3 times without removing the spontaneously differentiated colonies
prior to quantitative western blot analysis for Nanog, OCT4 and
SOX2 protein levels. This same procedure was used on control
iPS cells that were not treated with maxadilan. iPS cells (at a
density of 1610
6 cells) were lysed with RIPA buffer containing a
protease inhibitor cocktail (Bocai Biotechnology) and sonicated on
ice. The sonicated material was then centrifuged for 20 min at
15,0006rpm at 4uC, and the supernatant was collected. Fifty
Micrograms of total protein as determined by the BCA method
(Pierce) were separated on 10% SDS-PAGE gels and transferred
onto a PVDF membrane (Bio-Rad). The membrane was
incubated overnight at 4uC with the following primary antibodies:
rabbit polyclonal anti-PAC1 antibody (1:2000, Santa Cruz), rabbit
polyclonal anti-OCT4 antibody (1:1000, Cell Signaling), rabbit
polyclonal anti-Nanog antibody (1:1000, Cell Signaling), rabbit
monoclonal anti-SOX2 antibody (1:1000, Cell Signaling) and
rabbit monoclonal anti-b-actin antibody (1:3000, Cell Signaling).
The membrane was incubated with the goat anti-rabbit IgG
secondary antibody (1:3000; Santa Cruz) for 1 h at room
temperature. After adding the ECL chemiluminescence reagent
(Pierce), the membrane was incubated with developer solution for
1 min and with a fixative for 0.5 min. Quantitation of band
intensities was performed by scanning the immunostaining band
(Tanon2500)and analyzing the image with ImageJ 1.39 software.
Viability of iPS cells after UVC irradiation
One hundred microliters of the single-cell iPS cell suspension
(1610
4 cells) were seeded onto each well of a 96-well plate coated
with Matrigel. iPS cells were cultured in mTeSR1 medium in 96-
well plates to produce colonies at 80%–90% confluence. Ten
microliters of maxadilan (at 0 nM, 3 nM, 5 nM, 10 nM, 20 nM,
30 nM and 50 nM) [12] were added to each well, and the plates
were incubated at 37uC for 1 h. Cells were washed with phosphate
buffered solution (PBS) and subsequently exposed to 50 J/m
2,
75 J/m
2 and 100 J/m
2 ultraviolet C (UVC) at 254 nm (SPEC-
TRONICS, EBF-260C). Fresh culture medium and the appro-
priate concentrations of maxadilan were added, and cells
incubated for 24 h. Control wells contained iPS cells cultured in
mTeSR1 medium and were not irradiated with UVC. iPS cell
viability was measured by WST-8 analysis using the Cell Counting
Kit-8 (CCK-8) (Dojindo). The samples were stained with 10 mlo f
the CCK-8 solution and incubated on the plate in a CO2
incubator for 3 h. Absorbance (OD) of the iPS cells at a
wavelength of 450 nm was spectrophotometrically measured with
a microplate reader equipped with the Magellan (5.0) software
(Tecan Safire2, Switzerland).
Annexin V and propidium iodide (PI) assays
iPS cells were cultured in mTeSR1 medium in 6-well plates to
produce colonies at 80%–90% confluence. The iPS cells were
irradiated with UVC as described above. The UVC+30 nM
maxadilan iPS samples were treated with 30 nM of maxadilan for
1 h prior to exposure to 100 J/m
2 UVC, and the UVC+0n M
maxadilan iPS samples were exposed to 100 J/m
2 UVC in the
absence of maxadilan. After iPS cells were exposed to UVC, fresh
culture medium and the appropriate concentration of maxadilan
were added to each well, and the cells were incubated for 7 h.
Control wells containing iPS cells were cultured in mTeSR1
medium without UVC irradiation. To detect early apoptotic
activity, an Annexin V-FITC/PI Apoptosis Detection Kit (Key-
GEN) was used according to the manufacturer’s instructions. iPS
cells were washed with cold PBS and added to 200 ml of the
Annexin V-binding buffer. After the samples were stained with
2 ml of FITC-labeled Annexin V and 2 ml of PI, the samples were
immediately analyzed by flow cytometry (BD FACSAria
TM).
Terminal transferase dUTP nick end labeling (TUNEL) assays
iPS cells were cultured in mTeSR1 medium in 6-well plates to
produce colonies at 80%–90% confluence and irradiated with
UVC as described above. The UVC+30 nM maxadilan iPS
sample was treated with 30 nM maxadilan for 1 h prior to
exposure to 100 J/m
2 UVC, whereas the UVC+0 nM maxadilan
iPS group was exposed to 100 J/m
2 UVC without pretreatment
with maxadilan. After the iPS cells were exposed to UVC, fresh
culture medium and the appropriate concentration of maxadilan
were added to each well, and the cells were incubated for 9 h.
Control wells contained iPS cells cultured in mTeSR1 medium
and did not receive UVC radiation. To assess cellular apoptosis, a
one-step TUNEL Assay Kit was used according to the
manufacturer’s instructions (KeyGEN). Biotinylated fluorescein-
dUTP was incorporated into late-stage fragmented DNA using
terminal deoxynucleotidyl transferase, and the fluorescein was
measured using a fluorescence plate reader (Multilabel Counter
1420, VICTOR3V, Perkin Elmer). An excitation wavelength of
480 nm and an emission wavelength of 520 nm were utilized.
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To identify the signaling mechanism by which maxadilan
protects against UVC-induced cell death, we measured the activity
of caspase-3 and caspase-9 in iPS cells treated with maxadilan after
UVC irradiation. iPS cells were cultured in mTeSR1 medium in
6-well plates to produce colonies at 80%–90% confluence. The
UVC+30 nM maxadilan iPS cells were treated with 30 nM of
maxadilan for 1 h prior to exposure to 100 J/m
2 UVC, whereas
the UVC+0 nM maxadilan iPS cells were exposed to 100 J/m
2
UVC without any pretreatment with maxadilan. After the iPS cells
were exposed to UVC, fresh culture medium and the appropriate
concentration of maxadilan were added to each well, and the cells
were incubated for 6 h. Control wells containing iPS cells were
cultured in mTeSR1 medium and did not undergo UVC
irradiation. iPS cells were measured by a caspase-3 and caspase-
9 Colorimetric Assay Kit (KeyGEN) and the BCA Protein Assay
Kit (KeyGEN) according to the manufacturer’s instructions. For
analysis of caspase activity, cells were lysed for 60 min on ice in
lysis buffer, and 50 ml of the reaction buffer was added to 50 mlo f
the cellular supernatant solution (containing 50 mg of soluble
protein) and further incubated with 5 ml of caspase-3 and caspase-
9 substrates for 4 h. Absorbance (OD) was read spectrophotomet-
rically using a microplate reader (Tecan Safire2, Switzerland).
Excitation and emission wavelengths were set at 400 and 500 nm,
respectively.
Karyotype analysis
iPS cells were incubated with 100 nM maxadilan (the optimal
concentration of maxadilan to promote proliferation of iPS cells,
data not shown) for 24 h on day 5 after passaging. The iPS cells
were subsequently passaged three times without removing the
spontaneously differentiated colonies. iPS cells that were not
treated with maxadilan served as the control. iPS cells were
incubated with 0.05 mg/ml of colcemid (Invitrogen) for 150 min
at 37uC in a 5% CO2 incubator. Cells were washed with PBS and
trypsinized for 2 min at room temperature. Cells were fixed in
methanol/glacial acetic acid (3:1) three times and then dropped
onto slides for chromosome spreads. The slides were baked
overnight at 55uC, treated with 0.05% trypsin for 30 s and stained
with Giemsa solution.
Reverse Transcription Polymerase Chain Reaction
(RT-PCR) and Real-Time Quantitative Polymerase Chain
Reaction (RT-qPCR) analysis
PAC1 was detected by RT-PCR in iPS cells. iPS cells were
pretreated with 100 nM of maxadilan for 24 h and passaged 3
times without removing the spontaneously differentiated colonies
prior to RT-qPCR analysis for OCT4, Nanog, SOX2, Rex1, UTF1,
TERT, NESTIN and PAX6 gene expression levels. This same
procedure was used on control iPS cells that were not pretreated
with maxadilan. Primer sequences are shown in Table 1. Total
RNA from iPS cells was isolated using TRIzol, and the resulting
RNA samples were quantified by measuring the OD at 260 nm;
the OD 260/280 ratios for all RNA samples were between 1.8 and
2.1. Total RNA (2 mg) was reverse transcribed in a 20 ml reaction
mixture containing 4 mlo f5 6Reverse Transcriptase Buffer, 2 ml
dNTPs, 1 ml RNase inhibitor, 1 ml oligo-dT, 1 ml AMV Reverse
Transcriptase, 9 ml DEPC H2O, and 200 U of Reverse Tran-
scriptase (M-MLV) at 42uC for 1 h. The cDNA was synthesized,
diluted and used for RT-PCR for PAC1 andb-actin. Total cDNA
was used to perform qPCR on the CFX96 Real-Time PCR
Detection System (Bio-Rad). The reaction mixture consisted of
12.5 ml SYBRH Premix Ex Taq
TM (26), 0.5 ml forward and reverse
primers (10 mM), 2 ml diluted cDNA and 9.5 ml ddH2O. The
reaction conditions were 95uC for 30 s, followed by 40 cycles of
95uC for 5 s, 60uC for 30 s. The relative expression of the genes
was normalized against GAPDH or b-actin. Melting curves were
examined for the quality of the PCR amplification of each sample,
and quantification was performed using the comparative CT
(2
2DDCT) method [13].
In vitro differentiation
To examine in vitro differentiation, iPS cells treated with 100 nM
maxadilan for 24 h were cultured using a 24-well plate with ultra-
low adhesiveness to produce embryoid bodies (EBs) in suspension.
The EBs were subsequently cultured in differentiation medium,
which consisted of 80% DMEM/F12, 20% Knockout Serum
Replacement, 1 mM L-glutamine, 0.1 mM b-mercaptoethanol
and 0.1 mM non-essential amino acids (Gibco). Control iPS cells
were not treated with maxadilan. iPS cells aggregated and
generated EBs for 18 days. The attached EBs expanded and
Table 1. List of primers.
Primers Sequences (59to 39)
GeneBank
Number
GAPDH total-F AGAAGGCTGGGGCTCATTTG BC059110
GAPDH total-R AGGGGCCATCCACAGTCTTC
b-actin total-F TGAAGTGTGACGTGGACATC NM_001101.3
b-actin total-R GGAGGAGCAATGATCTTGAT
PAC1 total-F GGGTTCCTATTGGTTAGTTGGT NM_001118.4
PAC1 total-R GGCTGGTGTTTAGACAGAGTTCC
Nanog total-F CAAGAACTCTCCAACATCCTGAAC NC_000001
Nanog total-R CTGCGTCACACCATTGCTATTC
OCT4 total-F GAAGGATGTGGTCCGAGTGT NC_000006
OCT4 total-R GTGAAGTGAGGGCTCCCATA
SOX2 total-F ATGCACCGCTACGACGTGA NM_003106.3
SOX2 total-R CTTTTGCACCCCTCCCATTT
REX1 total-F AAACGGGCAAAGACAAGACAC NM_174900.3
REX1 total-R ATAGCACACATAGCCATCACATAA
UTF-1 total-F CGCCGCTACAAGTTCCTTAAA NM_003577.2
UTF-1 total-R GGATCTGCTCGTCGAAGGG
TERT total-F CGGAAGAGTGTCTGGAGCAA NM_001193376.1
TERT total-R GGATGAAGCGGAGTCTGGA
NESTIN total-F AACAGCGACGGAGGTCTCTA NC_000012
NESTIN total-R TTCTCTTGTCCCGCAGACTT
PAX6 total-F TTGCTGGAGGATGATGACAGAGGAA NM_001604
PAX6 total-R TTCTGCATGCTGGCTCTGGCT
SOX1 total-F AACCAGGACCGGGTCAAACGG NM_005986
SOX1 total-R CGCTTCTCGGCCTCGGACATG
PPAR total-F CACACACCGAGGACTCTTGCG NC_000022
PPAR total-R AACAAACACGCGCGTCTCCGT
GATA4 total-F ACTCGGAGCTTCTCCGCCTTTG NC_000008
GATA4 total-R GGCCCGTCAGTCCCGGTAAC
FOXA2 total-F GAGGGAGGCGACAGCGTTAGCA NC_000020
FOXA2 total-R TGTCCCGCAGGTTGCTTGCTG
SOX17 total-F CGCACGGAATTTGAACAG NC_000008
SOX17 total-R CAGTAATATACCGCGGAGCTG
doi:10.1371/journal.pone.0033953.t001
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being seeded onto Matrigel-coated plates and cultured for 20 days.
RT-PCR was performed for the markers of ectoderm (SOX1,
NESTIN and PAX6), mesoderm (GATA4 and PPAR) and endoderm
(FOXA2 and SOX17), and RT-qPCR was performed for NESTIN
and PAX6 gene expression levels in these cells as described above.
Immunofluorescence assay
iPS cells were treated with 100 nM maxadilan for 24 h and
passaged 3 times without removing the spontaneously differenti-
ated colonies before the immunofluorescence assay was per-
formed. Control iPS cells were not treated with maxadilan. The
qualitative detection of Nanog, OCT-4, SOX2, SSEA-4 and
TRA-1-60 was determined by immunofluorescence utilizing a
fluorescence microscope (Leica DMRA, Germany), whereas the
quantitative detection of Nanog, OCT-4 was determined using a
microplate reader (Tecan Safire2, Switzerland). Excitation and
emission wavelengths were set at 495 and 520 nm, respectively,
and the fluorescence absorption (OD) was measured. Briefly, after
fixation in 4% paraformaldehyde for 30 min at room temperature,
iPS cells were permeabilized with 0.1% Triton-X 100 in
Dulbecco’s Phosphate Buffered Saline (DPBS) for 15 min at room
temperature, washed three times with DPBS and incubated with
DPBS containing 10% fetal bovine serum for 30 min at room
temperature. The cells were incubated with the primary antibodies
[rabbit polyclonal anti-OCT4 antibody (1:400, Cell Signaling),
rabbit polyclonal anti-Nanog antibody (1:800, Cell Signaling),
rabbit monoclonal anti-SOX2 antibody (1:400, Cell Signaling),
mouse monoclonal anti-SSEA-4 antibody (1:1000, Cell Signaling),
mouse monoclonal anti-TRA-1-60(S) antibody (1:1000, Cell
Signaling), rabbit polyclonal anti-AQP1 antibody (1:400; Santa
Cruz) served as a negative control] for 60 min, and then with the
secondary antibodies [mouse anti-rabbit IgG secondary antibody
(1:400; Santa Cruz), Goat anti-mouse IgG secondary antibody
(1:100; Bioss), Goat anti-mouse IgM secondary antibody (1:100;
Bioss)] for 60 min before staining with DAPI.
Statistical Analysis
Statistical analysis was performed with a software package
(SPSS16.0). The statistical significance comparing multiple sample
sets with the control was analyzed with a one-way ANOVA
followed by the Dunnett’s test. Comparisons between the two
groups were analyzed using Student’s t-tests. A p-value of less than
0.05 was considered statistically significant. Data are presented as
the means 6 SEM. All results were derived from three
independent experiments.
Results
Analysis of PAC1 in iPS cells
To determine if PAC1 was present in iPS cells, RT-PCR and
western blot analyses were performed. The primer sequences of
PAC1 were shown in Table 1. As shown in figure (Figure 1), PAC1
mRNA was clearly expressed in iPS cells and the results of western
blot indicated that iPS cells had three kinds of PAC1 isoforms. The
molecular weights of these PAC1 isoforms (1, 2 and 3) vary from
about 50 kDa to 80 kDa.
Test of iPS cell viability after UVC irradiation
Maxadilan markedly affected cell survival after UVC irradiation
(Figure 2). iPS cells that were exposed to 50 J/m
2, 75 J/m
2 and
100 J/m
2 UVC and treated with 30 nM maxadilan showed a
significant increase in cell viability compared with iPS cells that
were not treated with maxadilan. iPS cells that were irradiated
with 50 J/m
2, 75 J/m
2 and 100 J/m
2 UVC showed a 64.63%,
67.23% and 70.8% reduction in cell viability, respectively,
compared with the control group. The addition of 30 nM
maxadilan resulted in a 51.75%, 53.1% and 52.43% decrease in
cell viability, respectively, compared with the control group. iPS
cells exposed to 100 J/m
2 UVC and treated with 50 nM of
maxadilan also showed a significant increase in cell viability
compared with iPS cells that were not treated with maxadilan.
The viability of iPS cells after irradiation with 100 J/m
2 UVC was
reduced by 70.8% compared with the control group, and the
addition of 50 nM maxadilan displayed a 50.29% decrease
compared with the control group.
Annexin V and PI assays
Annexin V and PI were analyzed by flow cytometry to detect
apoptosis in iPS cells cultured under various treatments. During
the early stages of apoptosis, cells typically have an intact cell
membrane that are not stained with PI; however, externalization
of phosphatidylserine (membrane phospholipids) can be detected
by annexin V. Using this method, we found that the addition of
Figure 1. PAC1 mRNA and protein were expressed in iPS cells. The expression of PAC1 mRNA in iPS cells by RT-PCR analysis (a). The
expression of PAC1 protein in iPS cells by western blot analysis showed that there are three kinds of PAC1 isoforms (b). The molecular weights of
these PAC1 isoforms (1, 2 and 3) vary from about 50 kDa to 80 kDa.
doi:10.1371/journal.pone.0033953.g001
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dramatically reduced the ratio of early apoptotic cells compared
with iPS cells without maxadilan treatment. iPS cells irradiated with
100 J/m
2 UVC showed a 248% increase in the ratio of early
apoptotic cells compared with the control group, whereas cells
treated with 30 nM maxadilan under the same conditions displayed
a 158% increase compared with the control group (Figure 3 ).
TUNEL assays
A TUNEL assay was performed to assess the anti-apoptotic
effects of maxadilan in iPS cells irradiated with UVC. The values
of biotinylated fluorescein-dUTP were proportional to the volume
of fragmented DNA in apoptotic cells. Our data revealed that the
addition of 30 nM maxadilan to iPS cells irradiated with 100 J/m
2
UVC dramatically reduced the percentage of apoptotic cells
compared with iPS cells that were not treated with maxadilan. iPS
cells irradiated with UVC showed a 587% increase in the
percentage of apoptotic cells compared with control group, and
the addition of 30 nM maxadilan displayed only a 224% increase
in apoptotic cells compared with the control group (Figure 4).
Caspase-3 and caspase-9 assays
To analyze the apoptotic machinery of iPS cells induced by
UVC and the anti-apoptotic machinery of maxadilan, caspase-3
and caspase-9 assays were performed. Our data showed that the
addition of 30 nM maxadilan to iPS cells irradiated with 100 J/m
2
UVC significantly downregulated caspase-3 and caspase-9. iPS
cells irradiated with 100 J/m
2 UVC showed a 104% and 92%
increase in activity of the caspase-3 and caspase-9, respectively,
compared with the control group, and the addition of 30 nM
maxadilan displayed a 51% and 54% increase, respectively,
compared with the control group (Figure 5).
Figure 2. Effects of maxadilan at various concentrations in iPS cells exposed to UVC. Cell viability in iPS cells that were exposed to 50 J/
m
2, 75 J/m
2 and 100 J/m
2 UVC and treated with maxadilan (at 0 nM, 3 nM, 5 nM, 10 nM, 20 nM, 30 nM and 50 nM) was detected by WST-8 analysis.
iPS cells without UVC irradiation were used as control. Values are expressed as the mean of OD 6 SEM of three independent experiments. ** P,0.01
vs. control group using Dunnett’s test. #P,0.05 or ##P,0.01 vs. UVC+0 nM Maxadilan group using Dunnett’s test.
doi:10.1371/journal.pone.0033953.g002
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Karyotype analysis was performed to determine the effect of
maxadilan on the karyotype of iPS cells. Karyotype analysis of iPS
cells treated with 100 nM maxadilan revealed a normal chromo-
some complement of 46XX.
RT-PCR and RT-qPCR analysis
To understand the effect of maxadilan on the pluripotent state
of iPS cells and to determine if maxadilan produces neuronal
differentiation of iPS cells, we used RT-qPCR analysis to
quantitatively compare the gene expression levels of Nanog,
OCT4, SOX2, Rex1, UTF1, TERT, NESTIN and PAX6 between
control iPS cells and cells treated with 100 nM maxadilan. Our
data showed no significant difference in the gene expression levels
of Nanog, OCT4, SOX2, Rex1, UTF1, TERT, NESTIN and PAX6
between the two groups (Figure 6 and 7).
Western blot analysis
To determine the effect of maxadilan on the pluripotent state of
iPS cells, we used western blot analysis to quantitatively compare
Figure 3. Flow cytometric analysis of iPS cell apoptosis with various treatments. Percentage of early apoptotic cells in iPS cells that were
exposed to 100 J/m
2 UVC and treated with maxadilan (at 0 nM and 30 nM) were measured by flow cytometric analysis. iPS cells that were not
irradiated with UVC were used as control. The Q2 area represents cell necrosis, the Q3 area represents living cells and the Q4 area represents early
apoptotic cells. Data are expressed as the mean of percentage 6 S.E.M of three independent experiments. **P,0.01 vs. control group using
Dunnett’s test. ## P,0.01 vs. UVC+0 nM maxadilan group with the Student’s t-test.
doi:10.1371/journal.pone.0033953.g003
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iPS cells and cells treated with 100 nM maxadilan. Our data
showed that Nanog, OCT4 and SOX2 protein were clearly
expressed in iPS cells (Figure 8) and that there was not significant
difference in the protein levels of Nanog, OCT4 and SOX2
between the two groups (Figure 9).
In vitro differentiation
To characterize the ability of iPS cells treated with maxadilan to
differentiate in vitro, RT-PCR was used to measure the mRNA
levels of PAX6, SOX1, PPAR, GATA4, FOXA2, SOX17 and NESTIN
in cells of EBs from both the control group and the group treated
with 100 nM maxadilan. Our data showed that both of iPS cells
Figure 4. Comparison of Fluorescein-dUTP in iPS cells with various treatments by TUNEL assay. Fluorescein-dUTP of iPS cells that were
exposed to 100 J/m
2 UVC and treated with maxadilan (at 0 nM and 30 nM) was detected by TUNEL assays. iPS cells that did not receive UVC radiation
were used as control. Fluorescence values are given in arbitrary units and are expressed as the mean 6 S.E.M of three independent experiments.
**P,0.01 vs. control group using Dunnett’s test. #P,0.05 Vs UVC+0 nM maxadilan group with the Student’s t-test.
doi:10.1371/journal.pone.0033953.g004
Figure 5. Assessment of caspase-3 and caspase-9 activities in iPS cells with various treatments. Caspase-3 activity (A) and caspase-9
activity (B) in iPS cells that were exposed to 100 J/m
2 UVC and treated with maxadilan (at 0 nM and 30 nM) were measured by caspase-3 and
caspase-9 treatment. iPS cells that did not undergo UVC irradiation were used as control. The results are expressed as the mean of OD 6 S.E.M of
three independent experiments.*P,0.05 or **P,0.01 vs. control group using Dunnett’s test. #P,0.05 vs. UVC+0 nM maxadilan group using the
Student’s t-test.
doi:10.1371/journal.pone.0033953.g005
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ability to form EBs and further differentiate. The differentiated
cells from both groups expressed SOX1, PAX6, GATA4, PPAR,
FOXA2, SOX17 and NESTIN, which are important markers of
three embryonic layers (Figure 10). To determine whether
maxadilan could produce neuronal differentiation of iPS cells,
we analyzed the gene expression levels of NESTIN and PAX6 by
RT-qPCR in control EBs or those treated with 100 nM
maxadilan. Our data showed that there was no significant
difference in the gene expression levels of NESTIN or PAX6 in
the EBs between the control group and the maxadilan-treated
group (Figure 11).
Immunofluorescence assay
To determine the effect of maxadilan on the pluripotent state of
iPS cells, we examined the protein expression levels of Nanog,
OCT-4, SOX2, SSEA-4 and TRA-1-60 by immunofluorescence
in control cells and in cells treated with 100 nM maxadilan. We
found that both the control group and the group treated with
100 nM maxadilan expressed Nanog, OCT-4, SOX2, SSEA-4
and TRA-1-60(S) and maintained the characteristics of undiffer-
entiated stem cells (Figure 12). A quantitative assay of Nanog and
OCT4 protein levels also showed no significant differences in
expression between the two groups (Figure 13).
Discussion
In recent years, there has been significant advancement in the
technical aspects used to culture iPS cells. However,there is a
problem not yet resolved, which iPS cell culture conditions are still
limited by the low survival rate that commonly follows enzymatic
dissociation and iPS cells are vulnerable to several kinds of
apoptosis, including detachment-induced apoptosis (anoikis) [14]
and dissociation-induced apoptosis (nonanoikis) [15]. This char-
acteristic is an obstacle for the development of techniques to
manipulate and batch produce iPS cells. Some studies have shown
promising results to circumvent the problem of apoptosis in iPS
cell culture. Pakzad M et al. [14] reported that the addition of the
ROCK inhibitor Y-27632 to the extracellular matrix has both
anti-apoptotic effects and augments effect on cells. This group
concluded that the addition of Y-27632 to the extracellular matrix
could increase the plating efficiency of iPS cells during passage.
Ohgushi M et al. [15] showed that nonanoikis, caused by ROCK-
dependent hyperactivation of actomyosin in iPS cell culture, could
be efficiently inhibited by the myosin inhibitor blebbistatin. Wang
Figure 6. RT-PCR analysis of mRNA expression in iPS cells with or without maxadilan. RT-PCR analysis of Nanog, OCT4, PAX6, NESTIN,
UTF1, SOX2, Rex1, and TERT mRNA expression in iPS cells of both the control group (a) and iPS cells treated with 100 nM maxadilan (b). iPS cells that
were not treated with maxadilan served as the control.
doi:10.1371/journal.pone.0033953.g006
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33953Figure 7. RT-qPCR analysis of mRNA expression in iPS cells with or without maxadilan. Comparison of relative gene expression levels of
Nanog, OCT4, PAX6, NESTIN, UTF1, SOX2, Rex1 and TERT in iPS cells between the control group and iPS cells treated with 100 nM maxadilan by RT-
qPCR analysis. iPS cells that were not treated with maxadilan served as the control. Values are expressed as the mean of relative gene expression
levels 6 S.E.M of three independent experiments. There are no significant differences between the two groups (p.0.05 with the Student’s t-test).
doi:10.1371/journal.pone.0033953.g007
Figure 8. Western blot analysis in iPS cells with or without maxadilan. Western blot analysis of Nanog, OCT4 and SOX2 protein expression in
iPS cells of both the control group and iPS cells treated with 100 nM maxadilan. iPS cells that were not treated with maxadilan served as the control.
The results are representative of three independent experiments.
doi:10.1371/journal.pone.0033953.g008
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anoikis in culture, and anoikis could be inhibited by the addition of
bFGF to the medium. The identification of an anti-apoptotic drug
that is effective when added to iPS cell culture medium will help to
increase the scale of iPS cell culture, which will be critical for
future clinical applications.
PACAP is a member of the vasoactive intestinal peptide (VIP)/
secretin/glucagon family of peptides. PACAP and VIP belong to
the same family of peptides and have well-established trophic
properties through shared G protein-coupled receptor signaling
[4]. PACAP has at least three distinct receptors: PACAP receptor
1 (PAC1), VIP receptor 1 and VIP receptor 2. In 2004,Cazillis M
et al. [9] demonstrated that PAC1 was functionally expressed in
mouse ES cells and that PACAP may induce the differentiation of
ES cells into a neuronal phenotype. Subsequently, Hirose M et al.
[10] also showed that PAC1 was present in undifferentiated ES
cells. They found that the expression of PAC1 mRNA was further
upregulated after terminal differentiation into neurons, and the
expression of PAC1 mRNA markedly decreased after glial
differentiation. Utilizing an electrophysiological patch-clamp
technique, Chafai M et al. [17] reported in 2006 that PACAP
and VIP, which act via the PAC1 and VPAC2 receptors,
facilitated the generation of electrical activity in differentiating
ES cells. However, little is known about the presence and effects of
PAC1 in iPS cells. In this study, RT-PCR analysis demonstrated
clearly that PAC1 was present in human iPS cells. PAC1 belongs
to the B class of GPCR (G Protein Coupled Receptor). The PAC1
gene contains more than 18 exons, and alternative splicing of two
regions (the first extracellular (EC1) domain and/or the third
intracellular cytoplasmic (IC3) loop) of the PAC1 gene results in a
Figure 9. Comparison of protein expression levels in iPS cells with or without maxadilan. Comparison of protein expression levels of
Nanog, OCT4 and SOX2 in iPS cells between the control group and iPS cells treated with 100 nM maxadilan by western blot analysis. iPS cells that
were not treated with maxadilan served as the control. Results are normalized to b-actin. Values are expressed as the mean 6 S.E.M of three
independent experiments. There are no significant differences between the two groups (p.0.05 with the Student’s t-test).
doi:10.1371/journal.pone.0033953.g009
Figure 10. RT-PCR analysis of mRNA expression in EBs from iPS cells with or without maxadilan. RT-PCR analysis the mRNA levels of
PAX6, SOX1, PPAR, GATA4, FOXA2, SOX17 and NESTIN in the EBs from the control group (a) and from iPS cells treated with 100 nM maxadilan (b). iPS
cells that were not pretreated with maxadilan served as the control.
doi:10.1371/journal.pone.0033953.g010
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weights varied from about 50 kDa to 80 kDa [18]. In this study,
the western-blot result showed that iPS cells had three kinds of
PAC1 isoforms. It has been known that the structural divergency
of GPCRs, as a result of alternative splicing, can influence a
number of receptor properties, including ligand affinity, G-protein
coupling, and the regulation of intracellular signaling [19]. So we
need more assays to show the role of each isoform in mediating
effects the maxadilan on iPS cells.
PACAP and its receptor PAC1 are involved in cell proliferation,
differentiation and viability. For example, many studies have
reported that PACAP can protect cells from apoptosis, which
involves various kinds of cell lines, such as the olfactory epithelium
and olfactory placodal cells [6], cochlear cells [7], cardiomyocytes
[8], and cortical neurons [20]. After confirming the presence of
PAC1 in iPS cells, one of our priorities was to determine whether
PACAP could protect iPS cells from apoptosis. Therefore, we
utilized maxadilan, a PAC1-specific agonist, to investigate the anti-
apoptotic functions of PACAP. In this study, we found that
maxadilan provided significant protection of iPS cells from
apoptosis induced by UVC irradiation.
Apoptosis is a basic feature of all animal cells and is essential for
normal development and tissue homeostasis. However, despite the
fact that most apoptotic programs lead to similar morphological
and biochemical endpoints, the apoptotic machinery is variable
[21]. Identifying the apoptotic machinery of iPS cells induced by
UVC irradiation and the anti-apoptotic machinery that is affected
by maxadilan will help to define iPS applications. Among the
various molecules that take part in the apoptotic process, caspase
plays an important role during the initiation and effector phase of
apoptotic cell death. Caspase is secreted as an inactive protease
and can be activated autocatalytically, thereby unleashing the
‘‘caspase cascade’’ that amplifies the apoptotic signal. Caspase-3 is
a prototypical caspase and an important protease for the execution
of apoptosis [22]. Martin SA et al. [23] found that when an
apoptosis model was induced by UV, caspase-3 was activated by
the UV-induced apoptosis pathway. Woo M et al. [24] reported
that caspase-3-deficient ES cells were resistant to apoptosis
induced by UV irradiation. These results demonstrate that
caspase-3 is likely necessary for apoptosis following UV irradiation.
Moreover, in response to most apoptotic stimuli, multiple caspases
are interrelated and affect one another. For instance, caspase-9 is
one component of a complex that is critical for caspase-3
activation. By activating caspase-3, caspase-9 becomes the
upstream member of the apoptotic protease cascade [25]. Hakem
R et al. [26] found that both caspase-9
2/2 and caspase-3
2/2 ES
cells were resistant to apoptotic signals induced by UV irradiation.
They concluded that UV irradiation preferentially triggered the
activation of an apoptotic pathway involving caspase-9 and
caspase-3 in ES cells. In our study, iPS cells irradiated with
UVC showed a significant increase in caspase-3 and caspase-9
activities compared with the control group. We conclude that
caspase-3 and caspase-9 are involved in iPS cell apoptosis induced
by UVC. Alleviation or inhibition of caspase activity by the use of
physiological or pharmacological agents has been known to reduce
apoptosis [27]. Studies have demonstrated that PACAP can
prevent apoptosis and inhibit caspase-3 activation in another
apoptotic model and cell type [8,28]. We found that UVC
irradiation led to a marked increase in caspase-3 and caspase-9
activations and that maxadilan counteracted this effect. Our
observations strongly suggest that maxadilan protects iPS cells
from apoptosis. The anti-apoptotic role of maxadilan acts, at least
in part, by reducing the activation of caspase-3 and caspase-9.
However, the detailed anti-apoptotic signaling mechanisms of
maxadilan are not fully elucidated.
PACAP is a neurotrophic peptide. Several studies have
concluded that the PACAP/PAC1 system promoted neuronal or
astrocyte differentiation of neural progenitor cells (NPCs) [29].
However, others have shown that PACAP peptides are downreg-
ulated, preventing differentiation of NPCs and maintaining their
Figure 11. RT-qPCR analysis of mRNA expression in EBs from iPS cells with or without maxadilan. RT-qPCR analysis comparing the
relative gene expression levels of PAX6 and NESTIN in the EBs from the control group and from iPS cells treated with 100 nM maxadilan. iPS cells that
were not pretreated with maxadilan served as the control. Values are expressed as the mean of relative gene expression levels 6 S.E.M of three
independent experiments. There are no significant differences between the two groups (p.0.05 with the Student’s t-test).
doi:10.1371/journal.pone.0033953.g011
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could induce the differentiation of ES cells into a neuronal
phenotype. Therefore, we were interested to determine if
maxadilan could produce neuronal differentiation of iPS cells.
Both NESTIN and PAX6 are markers of neural progenitor cells,
the neuroectoderm and neural crest stem cells. These factors may
be utilized as markers of neural differentiation [31]. In this study,
PAX6 gene expression was lower in the iPS cells treated with
maxadilan than in the control group, but this difference was not
significant. In addition, the gene expression of NESTIN in both
control iPS cells and the maxadilan treatment group was nearly
identical. Moreover, there was not a significant difference between
the control and maxadilan-treated iPS cells in the gene expression
of NESTIN or PAX6 in cells derived from EBs. These data
demonstrated that maxadilan could not produce neuronal
differentiation of iPS cells (at least at this particular dosage).
Although mTeSR1 medium, which contains recombinant
human basic fibroblast growth factor and recombinant human
transforming growth factor b, was used, a very small number of
spontaneously differentiated cells were observed during the culture
and passage of iPS cells. We observed that the number of
spontaneously differentiated cells increased gradually if differen-
tiated colonies were not removed prior to 3 passages of iPS cell
culture. To understand the effect of maxadilan on the pluripotent
state of iPS cells, we quantitatively compared the relative gene
expression levels of Nanog, OCT4, SOX2, Rex1, UTF1 and TERT by
RT-qPCR in both control iPS cells and the maxadilan treatment
group. We also qualitatively examined the protein expression of
Nanog, OCT4, SOX2, SSEA-4 and TRA-1-60 while quantita-
tively compared the protein expression levels of Nanog and OCT4
by immunofluorescence between these two groups. In addition, we
used western blot analysis to examine the protein expression of
Figure 12. Immunofluorescence staining in iPS cells with or without maxadilan. Immunofluorescence examining the protein expression of
Nanog, OCT4, SOX2, SSEA-4 and TRA-1-60(s) in iPS cells of both the control group (a) and in iPS cells that had been treated with 100 nM maxadilan
(b). iPS cells that were not treated with maxadilan served as the control. iPS cells treated with rabbit polyclonal anti-AQP1 antibody served as a
negative control. Mouse anti-rabbit IgG secondary antibody, goat anti-mouse IgG secondary antibody and goat anti-mouse IgM secondary antibody
were respectively used as secondary antibodies in this experiment. All scale bars are 100 mm.
doi:10.1371/journal.pone.0033953.g012
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differences in gene expression of Nanog, OCT4, SOX2, Rex1, UTF1
and TERT between the control group and the maxadilan-treated
iPS cells. There were also no significant differences in protein
expression levels of Nanog, OCT4 by immunofluorescence assay
and Nanog, OCT4 and SOX2 by western blot analysis between
these two groups. Pluripotency markers, Nanog, OCT4, SOX2,
SSEA-4 and TRA-1-60(S) in maxadilan-treated iPS cells were
confirmed by immunofluorescence. These results demonstrate that
iPS cells may retain characteristics of undifferentiated stem cells
even after maxadilan treatment. Moreover, our data showed that
both of iPS cells treated with maxidalan and their nontreated
counterparts had the ability to form EBs and further differentiate.
The differentiated cells from both groups expressed the important
markers of three embryonic layers. Our data implied that
treatment of iPS cells with maxadilan does not affect their
pluripotent state and displayed a normal karyotype.
In conclusion, our results demonstrate that PAC1 is present in
human iPS cells. We also showed that maxadilan dramatically
increased iPS cell viability and reduced the percentage of
apoptotic cells after UVC irradiation. The anti-apoptotic effect
of maxadilan was correlated to the downregulation of caspase-3
and caspase-9. Concomitantly, maxadilan did not affect the
pluripotent state or karyotype of iPS cells. Our research suggests
that maxadilan may be used as an anti-apoptotic additive in iPS
cell culture.
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